Parasa, Fatima G.
HRN: 23-06-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/18/2023
05/24/2023
IV
500mg
Q6
Hepatic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes